On May 5, Salient hosted the second of 2 interactive webinars featuring live demonstrations of AI solutions addressing health supply chain challenges across Africa. The session drew > 65 supply chain leaders across government, global health institutions, and the private sector.
As part of ongoing research, Salient shared preliminary analyses. First, in conjunction with global health supply chain experts the team identified 7 key supply problems where AI can deliver the most impact today:
- High workforce cost and skill dependency
- Data management and report automation
- Fragmented data for decision-making
- Suboptimal inventory levels
- Inefficient and manual procurement
- Inaccurate demand forecasting; and
- Lack of serialization and track-and-trace.
Second, through rapid analysis, Salient preliminarily identified 19 in-market solutions addressing these challenges: Dematic, Addverb Technologies, PBR Life Sciences, V7 Labs, S4D Consulting, Exiger, Intrinseque Health, Distripha, Tecsys, Viebeg, inSupply Health, Logixity, Causal Foundry, Opian Tech, SAP Joule, Datup, Anaplan, TraceLink and PharmaSecure.
The session also featured live demonstrations from 2 solution providers.
Opian Technologies showcased ForLab Plus, an AI-enabled platform which tackles inaccurate demand forecasting by helping governments transition from assumption-based to consumption-based procurement. Deployed across 5,700+ facilities in Ethiopia in collaboration with the Ministry of Health, it has informed ~$180M in procurement decisions. S4D Consulting demonstrated Cognivo, a solution designed to address fragmented data by integrating data from siloed platforms into a unified, real-time intelligence view. The solution has been designed for deployment across Ghana, Zambia, and Rwanda.
Watch a recap of their live demos:
The full report, covering the AI solution landscape and key adoption considerations for governments, global health institutions, and supply chain leaders, will be released in July 2026. Subscribe to our monthly newsletter to receive it.
